Carrie Margeson, in Tutuhan, GU - Pharmacist

Carrie Margeson, is a Pharmacist based in Tutuhan, Guam. Carrie Margeson is licensed to practice in Florida (license number PS53591) and her current practice location is Bldg #50 Farenholt Ave, Tutuhan, Guam. She can be reached at her office (for appointments etc.) via phone at (670) 344-9354.

NPI number for Carrie Margeson is 1588200497 and her current mailing address is 125 Dungca Beach Way Apt 402, Tamuning, Guam. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1588200497.

Contact Information

	Carrie Margeson,
	Bldg #50 Farenholt Ave, Tutuhan, GU 96910
	(670) 344-9354
	Not Available

Healthcare Provider's Profile

Full Name	Carrie Margeson
Gender	Female
Speciality	Pharmacist
Location	Bldg #50 Farenholt Ave, Tutuhan, Guam
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1588200497
Provider Enumeration Date: 11/26/2019
Last Update Date: 11/26/2019

Medical Identifiers

Medical identifiers for Carrie Margeson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1588200497	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	0013320 (Connecticut)	Secondary
183500000X	Pharmacist	PS53591 (Florida)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Carrie Margeson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Carrie Margeson, 125 Dungca Beach Way Apt 402, Tamuning, GU 96913-3439 Ph: () -	Carrie Margeson, Bldg #50 Farenholt Ave, Tutuhan, GU 96910 Ph: (670) 344-9354

News Archive

UT Southwestern researcher wins prestigious award from International Atherosclerosis Society

Dr. Helen Hobbs, a preeminent researcher on the genetics of cholesterol metabolism at UT Southwestern Medical Center, has won a prestigious award from the International Atherosclerosis Society.

New discovery helps explain the persistent weakness after ACL reconstruction surgery

After an anterior cruciate ligament reconstruction surgery, it's common to experience quadriceps weakness, which was thought to be caused primarily by muscle atrophy, or shrinkage.

Surgical robots to incorporate senses comparable or even superior to humans

Surgeons make optimal use of all their senses to master difficult operations. When visibility is poor, they locate anatomy by palpation or they hear the optimal moment to stop drilling.

Afro-Caribbean patients with end stage kidney disease more likely to be hospitalized with COVID-19

Afro-Caribbean people with end stage kidney disease (ESKD) are more likely to be hospitalized with COVID-19 than other ethnicities, a study has found.

Efficacy and safety data on linagliptin and investigational compound empagliflozin* in various diabetes subpopulations presented by Boehringer Ingelheim and Eli Lilly and Company

Boehringer Ingelheim and Eli Lilly and Company today announced they will feature five oral and 12 poster presentations for linagliptin and the investigational compound empagliflozin* at the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD) which will take place in Barcelona, from 23 – 27 September. The presentations will add to the already existing body of data on safety and efficacy of these two compounds.

Carrie Margeson, - Pharmacist in Tutuhan, GU